CRIS Current Research Information System

DE MARCO, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.646
AS - Asia 3.112
EU - Europa 2.660
AF - Africa 280
SA - Sud America 152
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.601
CN - Cina 903
SG - Singapore 836
IT - Italia 774
VN - Vietnam 763
GB - Regno Unito 641
DE - Germania 306
HK - Hong Kong 224
RU - Federazione Russa 155
FR - Francia 153
SE - Svezia 142
IN - India 127
BR - Brasile 98
UA - Ucraina 96
IE - Irlanda 91
TG - Togo 90
CI - Costa d'Avorio 69
FI - Finlandia 56
ZA - Sudafrica 56
EE - Estonia 54
JP - Giappone 54
NL - Olanda 47
BG - Bulgaria 38
CA - Canada 30
SC - Seychelles 30
JO - Giordania 26
KR - Corea 24
PH - Filippine 23
ID - Indonesia 22
NG - Nigeria 22
CH - Svizzera 19
AR - Argentina 18
BE - Belgio 15
ES - Italia 15
HR - Croazia 13
IQ - Iraq 13
PK - Pakistan 13
TH - Thailandia 13
TR - Turchia 12
CL - Cile 11
MX - Messico 11
IR - Iran 10
AT - Austria 9
CO - Colombia 9
TW - Taiwan 9
EC - Ecuador 8
LB - Libano 8
RO - Romania 7
BD - Bangladesh 5
PL - Polonia 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
NP - Nepal 4
PE - Perù 4
UZ - Uzbekistan 4
GR - Grecia 3
IL - Israele 3
LT - Lituania 3
AU - Australia 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
KZ - Kazakistan 2
ML - Mali 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
HU - Ungheria 1
JM - Giamaica 1
KI - Kiribati 1
LK - Sri Lanka 1
MA - Marocco 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VE - Venezuela 1
Totale 9.854
Salva come PNG Salva come JPEG
Città #
Singapore 556
Southend 543
Ashburn 379
Fairfield 375
Chandler 254
Santa Clara 236
Bologna 215
San Jose 207
Hong Kong 197
Woodbridge 190
Seattle 165
Wilmington 155
Cambridge 149
Hanoi 147
Beijing 141
Ho Chi Minh City 135
Ann Arbor 133
Princeton 129
Houston 127
Dong Ket 107
Lomé 90
Dublin 87
Nanjing 80
Boardman 72
Abidjan 69
Lauterbourg 63
Westminster 59
Padova 55
Los Angeles 52
Jinan 50
Jacksonville 49
Helsinki 48
Berlin 46
Milan 43
Tokyo 43
Dallas 38
Sofia 38
Saint Petersburg 36
Shenyang 34
Council Bluffs 30
Changsha 29
Hebei 29
Bremen 28
Shanghai 28
Hefei 27
Amman 26
Haiphong 25
Guangzhou 24
Redondo Beach 24
Da Nang 23
Medford 23
Abeokuta 22
Tianjin 22
Buffalo 21
Redmond 21
San Diego 20
Frankfurt am Main 19
New York 18
Munich 17
Turin 17
Zhengzhou 17
Hangzhou 15
Shenzhen 15
Nanchang 13
Seoul 13
Chicago 12
Forlimpopoli 12
Biên Hòa 11
Brussels 11
Falkenstein 11
Rome 11
Toronto 11
Haikou 10
Jakarta 10
Lahore 10
Mülheim 10
Redwood City 10
Wuhan 10
Yubileyny 10
Des Moines 9
Falls Church 9
Jiaxing 9
London 9
Ningbo 9
Norwalk 9
Orem 9
Phoenix 9
São Paulo 9
Atlanta 8
Dearborn 8
Denver 8
Moscow 8
Zurich 8
Baghdad 7
Brooklyn 7
Hải Dương 7
Modena 7
Montreal 7
Ravenna 7
Shijiazhuang 7
Totale 6.477
Salva come PNG Salva come JPEG
Nome #
Modern tools for the chemical ligation and synthesis of modified peptides and proteins 277
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 265
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 252
Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization 235
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists 232
A simple route towards peptide analogues containing substituted (S)- or (R)-tryptophans 218
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 217
Integrin-targeting dye-doped peg-shell/silica-core nanoparticles mimicking the proapoptotic Smac/DIABLO protein 207
Diagnostic implementation of fast and selective integrin-mediated adhesion of cancer cells on functionalized zeolite L monolayers 205
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 203
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 201
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 199
Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects 198
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 197
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 197
Controlling Cyclopeptide Backbone Conformation with β/α-Hybrid Peptide–Heterocycle Scaffolds 194
Convenient Synthesis of the Antibiotic Linezolid via an Oxazolidine-2,4-dione Intermediate Derived from the Chiral Building Block Isoserine 182
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 181
Synthesis and assay of retro-α4β1 integrin-targeting motifs 181
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 179
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 176
Analytical pyrolysis of dipeptides containing proline and amino acids with polar side chains. Novel 2,5-diketopiperazine markers in the pyrolysates of proteins 174
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 171
In-peptide synthesis of di-oxazolidinone and dehydroamino acid-oxazolidinone motifs as β-turn inducers 170
Controlled solid phase peptide bond formation using N-carboxyanhydrides and PEG resins in water. 168
NEW PEPTIDOMIMETIC α4β1-INTEGRIN ANTAGONISTS FOR REDUCING INFLAMMATION AND ALLERGIC REACTIONS 163
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 163
Cyclopeptide analogs for generating new molecular and 3D diversity 160
Selective detection of α4β1 integrin (VLA-4)-expressing cells using peptide-functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites 159
Peptide direct growth on poly(acrylic acid)/poly(vinyl alcohol) electrospun fibers coated with branched poly(ethylenimine): A solid-phase approach for scaffolds biofunctionalization 158
Heterocyclic Scaffolds in the Design of Peptidomimetic Integrin Ligands: Synthetic Strategies, Structural Aspects, and Biological Activity 158
Synthesis and Conformational Analysis of Cyclotetrapeptide Mimetic beta-Turn Templates and Validation as 3D Scaffolds 158
Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-d-alanine 156
Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions 153
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 152
Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold 151
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 147
Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans 144
Strategies to Improve Bioavailability and In Vivo Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2 142
Synthesis of beta2- and beta2,2-homo-Freidinger Lactam analogs, conformational analysis, and applications in Medicinal Chemistry 139
Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic 137
Synthesis and Analysis of the Conformational Preferences of 5- Aminomethyloxazolidine-2,4-dione Scaffolds: First Examples of beta2- and beta2,2-Homo-Freidinger Lactam Analogues 134
Tryptophan-Containing Non-Cationizable Opioid Peptides - A new chemotype with unusual structure and in vivo activity 132
Peptidomimetic Scaffolds for the Discovery of New Bioactive Compounds. Cyclotetrapeptide Analogues Based on a 13-Membered, Partially Modified Retro-Inverso Structure. Applications to the synthesis of Cancer Cell Adhesion Inhibitors 129
Interactions between atypical opioid agonists and MOR 128
Expedient synthesis of pseudo-Pro-containing peptides: towards constrained peptidomimetics and foldamers 127
Peptidomimetic probes for modulating α4β1 integrin activity 124
Synthesis of Constrained Peptidomimetics Containing 2-Oxo-1,3-oxazolidine-4-carboxylic Acids 122
Dehydro-beta-amino acid containing peptidomimetics as integrin receptor ligands 121
Investigation on MOR receptor activation by atypical mechanisms 118
Development and characterization of Endomorphin-1 analogues as novel potential analgesic drugs. 118
One-step synthesis of constrained peptidomimetics including oxazolidinones and/or dehydro-amino acids, and application to the design of bioactive compounds 114
Hybrid alfa/beta-dipeptide scaffolds as inductors of constrained conformations 113
Synthesis of tripeptides containing D-Trp substituted at indole ring, and assessment of MOR affinity and in vivo central antinociception. 108
Nanostructured Materials for the Detection of Markers of Asthma and Other Correlated Inflammatory Diseases 108
OPIOID RECEPTOR-TARGETING CYCLOPEPTIDES FOR PAIN MANAGEMENT: NEW STRUCTURES, NEW MECHANISMS 106
Opioid activity profiles of peptides containing overlapping portions of CJ-15,208 and CycloEM, and identification of the bioactive conformations 105
null 105
TRYptophan-COntaining Non-Cationizable Opioid PeptideS (TRYCONCOPS): A new paradigm for opioid peptides 98
null 93
Endomorphin-1 analogues as novel and highly selective MOPr agonists: design and characterization of innovative analgesic drugs 92
Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model 91
Trypoids, a novel group of mu-opioid receptor-selective di- and tri-peptides: design and characterization of novel analgesics 80
Exploring the biochemical, technical and applicative characteristics of pullulan produced by different strains of Aureobasidium pullulans 32
Totale 10.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021281 0 0 0 0 0 0 0 0 0 40 43 198
2021/20221.158 171 89 54 42 126 60 37 127 41 55 160 196
2022/20231.188 108 180 52 172 98 95 38 59 212 22 104 48
2023/2024387 32 46 23 30 41 86 18 22 12 20 28 29
2024/20251.509 46 233 141 97 304 70 174 55 10 51 32 296
2025/20262.778 205 237 238 194 337 176 403 98 638 252 0 0
Totale 10.017